Search research articles
Contact Us
Filters
Showing results (21-30 of 135) with videos related to
Page
of 14
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
September 20, 2024
Screening of psoriatic arthritis by dermatologists - a German nationwide survey
Andreas Pinter, Matthias Hofmann, Roland Kaufmann, et al.
Journal of Drugs in Dermatology : JDD
|
March 7, 2022
Pooled Analysis Demonstrating Superior Patient- Reported Psoriasis Treatment Outcomes for Calcipotriene/ Betamethasone Dipropionate Cream Versus Suspension/Gel
April Armstrong, Andreas Pinter, Johan Selmer, et al.
Experimental Dermatology
|
August 5, 2016
Histone deacetylase inhibitors interfere with angiogenesis by decreasing endothelial VEGFR-2 protein half-life in part via a VE-cadherin-dependent mechanism
Igor Hrgovic, Monika Doll, Andreas Pinter, et al.
Journal of Medical Economics
|
January 14, 2025
Real-world psoriasis treatment patterns and disease burden in Germany, with a focus on biologics and apremilast: data from a German statutory health insurance database
Andreas Pinter, Marcus Schulte, Nils Kossack, et al.
Dermatology and Therapy
|
July 13, 2019
ERAPSO: Revealing the High Burden of Obesity in German Psoriasis Patients
Peter E H Schwarz, Andreas Pinter, Nima Melzer, et al.
Dermatology and Therapy
|
April 11, 2019
Tolerability and Efficacy of a Medical Device Repairing Emollient Cream in Children and Adults with Mild to Moderate Atopic Dermatitis
Andreas Pinter, Marie-Dominique Thouvenin, Adeline Bacquey, et al.
Clinical and Experimental Dermatology
|
April 29, 2026
Patient and clinician reported outcomes of calcipotriol/betamethasone dipropionate PAD-cream for the treatment of adult patients with scalp psoriasis under real-world conditions: results from the prospective, non-interventional, multicentre PRO-SCALP study
Jose Luis López Estebaranz, Anthony Bewley, Andreas Pinter, et al.
Acta Dermato-Venereologica
|
February 13, 2024
Clinically Meaningful Responses to Dupilumab Among Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis who did Not Achieve Clear or Almost Clear Skin According to the Investigator's Global Assessment: A Post Hoc Analysis of a Phase 3 Trial
Michael J Cork, Benjamin Lockshin, Andreas Pinter, et al.
Dermatologic Therapy
|
November 6, 2021
Absolute Psoriasis Area and Severity Index as a valuable marker to determine initial treatment response in psoriasis patients treated with guselkumab in routine clinical care
Ulrich Seidl, Andreas Pinter, Dagmar Wilsmann-Theis, et al.
Dermatology and Therapy
|
December 18, 2021
Impact of Risankizumab on PASI90 and DLQI0/1 Duration in Moderate-to-Severe Psoriasis: A Post Hoc Analysis of Four Phase 3 Clinical Trials
Mark G Lebwohl, Ahmed M Soliman, Hongbo Yang, et al.
Page
of 14
Search research articles
Search
Showing results (21-30 of 135) with videos related to
Sort By:
Page
of 14
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
September 20, 2024
Screening of psoriatic arthritis by dermatologists - a German nationwide survey
Andreas Pinter, Matthias Hofmann, Roland Kaufmann, et al.
Journal of Drugs in Dermatology : JDD
|
March 7, 2022
Pooled Analysis Demonstrating Superior Patient- Reported Psoriasis Treatment Outcomes for Calcipotriene/ Betamethasone Dipropionate Cream Versus Suspension/Gel
April Armstrong, Andreas Pinter, Johan Selmer, et al.
Experimental Dermatology
|
August 5, 2016
Histone deacetylase inhibitors interfere with angiogenesis by decreasing endothelial VEGFR-2 protein half-life in part via a VE-cadherin-dependent mechanism
Igor Hrgovic, Monika Doll, Andreas Pinter, et al.
Journal of Medical Economics
|
January 14, 2025
Real-world psoriasis treatment patterns and disease burden in Germany, with a focus on biologics and apremilast: data from a German statutory health insurance database
Andreas Pinter, Marcus Schulte, Nils Kossack, et al.
Dermatology and Therapy
|
July 13, 2019
ERAPSO: Revealing the High Burden of Obesity in German Psoriasis Patients
Peter E H Schwarz, Andreas Pinter, Nima Melzer, et al.
Dermatology and Therapy
|
April 11, 2019
Tolerability and Efficacy of a Medical Device Repairing Emollient Cream in Children and Adults with Mild to Moderate Atopic Dermatitis
Andreas Pinter, Marie-Dominique Thouvenin, Adeline Bacquey, et al.
Clinical and Experimental Dermatology
|
April 29, 2026
Patient and clinician reported outcomes of calcipotriol/betamethasone dipropionate PAD-cream for the treatment of adult patients with scalp psoriasis under real-world conditions: results from the prospective, non-interventional, multicentre PRO-SCALP study
Jose Luis López Estebaranz, Anthony Bewley, Andreas Pinter, et al.
Acta Dermato-Venereologica
|
February 13, 2024
Clinically Meaningful Responses to Dupilumab Among Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis who did Not Achieve Clear or Almost Clear Skin According to the Investigator's Global Assessment: A Post Hoc Analysis of a Phase 3 Trial
Michael J Cork, Benjamin Lockshin, Andreas Pinter, et al.
Dermatologic Therapy
|
November 6, 2021
Absolute Psoriasis Area and Severity Index as a valuable marker to determine initial treatment response in psoriasis patients treated with guselkumab in routine clinical care
Ulrich Seidl, Andreas Pinter, Dagmar Wilsmann-Theis, et al.
Dermatology and Therapy
|
December 18, 2021
Impact of Risankizumab on PASI90 and DLQI0/1 Duration in Moderate-to-Severe Psoriasis: A Post Hoc Analysis of Four Phase 3 Clinical Trials
Mark G Lebwohl, Ahmed M Soliman, Hongbo Yang, et al.
Page
of 14